182 related articles for article (PubMed ID: 29174014)
21. Ultrasmall inorganic nanoparticles: State-of-the-art and perspectives for biomedical applications.
Zarschler K; Rocks L; Licciardello N; Boselli L; Polo E; Garcia KP; De Cola L; Stephan H; Dawson KA
Nanomedicine; 2016 Aug; 12(6):1663-701. PubMed ID: 27013135
[TBL] [Abstract][Full Text] [Related]
22. Recent advances in green nanoparticulate systems for drug delivery: efficient delivery and safety concern.
Lam PL; Wong WY; Bian Z; Chui CH; Gambari R
Nanomedicine (Lond); 2017 Feb; 12(4):357-385. PubMed ID: 28078952
[TBL] [Abstract][Full Text] [Related]
23. Nanoparticles: pharmacological and toxicological significance.
Medina C; Santos-Martinez MJ; Radomski A; Corrigan OI; Radomski MW
Br J Pharmacol; 2007 Mar; 150(5):552-8. PubMed ID: 17245366
[TBL] [Abstract][Full Text] [Related]
24. Unique roles of nanotechnology in medicine and cancer.
Alam F; Naim M; Aziz M; Yadav N
Indian J Cancer; 2014; 51(4):506-10. PubMed ID: 26842179
[TBL] [Abstract][Full Text] [Related]
25. New perspectives of nanoneuroprotection, nanoneuropharmacology and nanoneurotoxicity: modulatory role of amino acid neurotransmitters, stress, trauma, and co-morbidity factors in nanomedicine.
Sharma HS; Sharma A
Amino Acids; 2013 Nov; 45(5):1055-71. PubMed ID: 24022705
[TBL] [Abstract][Full Text] [Related]
26. A platelet-inspired paradigm for nanomedicine targeted to multiple diseases.
Modery-Pawlowski CL; Kuo HH; Baldwin WM; Sen Gupta A
Nanomedicine (Lond); 2013 Oct; 8(10):1709-27. PubMed ID: 24074391
[TBL] [Abstract][Full Text] [Related]
27. Thrombocytopathy leading to impaired in vivo haemostasis and thrombosis in platelet type von Willebrand disease.
Kaur H; Corscadden K; Ware J; Othman M
Thromb Haemost; 2017 Feb; 117(3):543-555. PubMed ID: 28004055
[TBL] [Abstract][Full Text] [Related]
28. Thrombus inducing property of atomically thin graphene oxide sheets.
Singh SK; Singh MK; Nayak MK; Kumari S; Shrivastava S; Grácio JJ; Dash D
ACS Nano; 2011 Jun; 5(6):4987-96. PubMed ID: 21574593
[TBL] [Abstract][Full Text] [Related]
29. Toxicology of nanomaterials used in nanomedicine.
Zhao J; Castranova V
J Toxicol Environ Health B Crit Rev; 2011; 14(8):593-632. PubMed ID: 22008094
[TBL] [Abstract][Full Text] [Related]
30. Nanotechnology and glaucoma: a review of the potential implications of glaucoma nanomedicine.
Kim NJ; Harris A; Gerber A; Tobe LA; Amireskandari A; Huck A; Siesky B
Br J Ophthalmol; 2014 Apr; 98(4):427-31. PubMed ID: 24246373
[TBL] [Abstract][Full Text] [Related]
31. Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology.
Oberdörster G
J Intern Med; 2010 Jan; 267(1):89-105. PubMed ID: 20059646
[TBL] [Abstract][Full Text] [Related]
32. [Effects of ethanol on hemostasis].
Jelski W; Szmitkowski M
Pol Merkur Lekarski; 2008 Feb; 24(140):131-3. PubMed ID: 18634269
[TBL] [Abstract][Full Text] [Related]
33. Recent Advances in Nanomaterials Development for Nanomedicine and Cancer.
Abbasi Kajani A; Haghjooy Javanmard S; Asadnia M; Razmjou A
ACS Appl Bio Mater; 2021 Aug; 4(8):5908-5925. PubMed ID: 35006909
[TBL] [Abstract][Full Text] [Related]
34. Platelets and coagulation in thrombus formation: aberrations in the Scott syndrome.
van Geffen JP; Swieringa F; Heemskerk JW
Thromb Res; 2016 May; 141 Suppl 2():S12-6. PubMed ID: 27207414
[TBL] [Abstract][Full Text] [Related]
35. The Nanopharmacology and Nanotoxicology of Nanomaterials: New Opportunities and Challenges.
Radomska A; Leszczyszyn J; Radomski MW
Adv Clin Exp Med; 2016; 25(1):151-62. PubMed ID: 26935510
[TBL] [Abstract][Full Text] [Related]
36. Better safe than sorry: Understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications.
Fadeel B; Garcia-Bennett AE
Adv Drug Deliv Rev; 2010 Mar; 62(3):362-74. PubMed ID: 19900497
[TBL] [Abstract][Full Text] [Related]
37. Surface tunability of nanoparticles in modulating platelet functions.
Deb S; Raja SO; Dasgupta AK; Sarkar R; Chattopadhyay AP; Chaudhuri U; Guha P; Sardar P
Blood Cells Mol Dis; 2012 Jan; 48(1):36-44. PubMed ID: 22033068
[TBL] [Abstract][Full Text] [Related]
38. Synergistic platelet integrin signaling and factor XII activation in poly-N-acetyl glucosamine fiber-mediated hemostasis.
Fischer TH; Thatte HS; Nichols TC; Bender-Neal DE; Bellinger AD; Vournakis JN
Biomaterials; 2005 Sep; 26(27):5433-43. PubMed ID: 15860200
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the effects of nanoparticles on the therapeutic function of platelet: a review.
Zadeh Mehrizi T; Amini Kafiabad S
J Pharm Pharmacol; 2022 Feb; 74(2):179-190. PubMed ID: 34244798
[TBL] [Abstract][Full Text] [Related]
40. Application of nanotechnology in biomedicine.
Navalakhe RM; Nandedkar TD
Indian J Exp Biol; 2007 Feb; 45(2):160-5. PubMed ID: 17375555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
